Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.66M Sell
31,382
-997
-3% -$80.1K 0.03% 346
2026
Q1
$2.71M Buy
32,379
+1,633
+5% +$123K 0.03% 328
2025
Q4
$2.07M Sell
30,746
-4,774
-13% -$309K 0.03% 357
2025
Q3
$2.4M Buy
35,520
+4,787
+16% +$347K 0.03% 338
2025
Q2
$2.29M Buy
30,733
+245
+0.8% +$16.3K 0.03% 336
2025
Q1
$1.92M Sell
30,488
-102
-0.3% -$6.31K 0.03% 343
2024
Q4
$1.74M Sell
30,590
-2,048
-6% -$121K 0.03% 395
2024
Q3
$1.89M Buy
32,638
+9,742
+43% +$532K 0.03% 364
2024
Q2
$1.22M Buy
22,896
+15,126
+195% +$833K 0.02% 453
2024
Q1
$448K Buy
7,770
+1,799
+30% +$92.9K 0.01% 447
2023
Q4
$286K Buy
+5,971
New +$285K 0.01% 501
2023
Q2
Sell
-3,561
Closed -$215K 473
2023
Q1
$215K Buy
+3,561
New +$217K 0.01% 448

Other funds holding CTVA

Choreo LLC's CTVA Position: Q2 2026 in Review

Choreo LLC reduced its Corteva (CTVA) stake by 3.1% in Q2 2026, selling an estimated $80.1K and leaving 31,382 shares worth $2.66M. The position accounts for 0.03% of the portfolio, ranked #346.

Choreo LLC first reported a position in CTVA in Q1 2023 and has held it in 12 quarters since. The position peaked at $2.71M in Q1 2026. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Choreo LLC held 31,382 shares of Corteva worth $2.66M as of Q2 2026.
  • Choreo LLC sold 997 Corteva shares in Q2 2026, an estimated $80.1K.
  • Corteva made up 0.03% of Choreo LLC's portfolio in Q2 2026, its #346 holding.
  • Choreo LLC first reported a position in Corteva in Q1 2023 and has held it in 12 quarters since.
  • Choreo LLC's Corteva position peaked at $2.71M in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.